Sartorius Aktiengesellschaft/€SRT
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft is a German company engaged in the development, manufacturing, and distribution of laboratory equipment and bioprocess solutions. The company's core business is centered around two main segments: Bioprocess Solutions, which includes products for the production of biopharmaceuticals, such as filters, bags, and bioreactors, and Lab Products & Services, offering laboratory instruments like balances and pipettes for various research applications. Founded in 1870, Sartorius is headquartered in Göttingen, Germany, and maintains a global presence with operations in Europe, Asia, and the Americas. Its strategic positioning is reinforced by a strong focus on innovation and comprehensive product offerings catering to the biopharmaceutical industry. Competitive strengths include robust R&D capabilities and a well-integrated supply chain that supports rapid adaptation to industry demands. Sources: Sartorius Corporate Website, Annual Reports.
Ticker
€SRT
Sector
Primary listing
XETRA
Industry
Life Sciences Tools & Services
Headquarters
Employees
13,573
ISIN
DE0007165607
Website
SRT Metrics
BasicAdvanced
€13B
-
-
1.24
€0.73
0.42%
Price and volume
Market cap
€13B
Beta
1.24
52-week high
€195.00
52-week low
€161.20
Dividend rate
€0.73
Financial strength
Current ratio
1.458
Quick ratio
0.822
Long term debt to equity
109.459
Total debt to equity
120.637
Dividend payout ratio (TTM)
53.03%
Interest coverage (TTM)
2.15%
Profitability
EBITDA (TTM)
753.3
Gross margin (TTM)
45.27%
Net profit margin (TTM)
2.78%
Operating margin (TTM)
13.05%
Effective tax rate (TTM)
26.50%
Revenue per employee (TTM)
€250,000
Management effectiveness
Return on assets (TTM)
2.71%
Return on equity (TTM)
4.12%
Valuation
Dividend yield (TTM)
0.42%
Forward dividend yield
0.42%
Growth
Revenue change (TTM)
3.99%
3-year revenue growth (CAGR)
-2.21%
10-year revenue growth (CAGR)
13.79%
3-year dividend per share growth (CAGR)
-16.26%
10-year dividend per share growth (CAGR)
10.82%
Bulls say / Bears say
Sartorius reported a 6.5% increase in sales revenue for Q1 2025, reaching EUR 883 million, driven by strong demand in the Bioprocess Solutions division. (marketscreener.com)
The company's underlying EBITDA rose by 12.2% to EUR 263 million in Q1 2025, with a margin expansion to 29.8%, indicating improved operational efficiency. (marketscreener.com)
Analysts from AlphaValue/Baader Europe have a 'Positive' outlook on Sartorius, citing strong consumables demand in Q1 2025. (marketscreener.com)
JP Morgan expressed a cautious stance on Sartorius's Q1 2025 results, expecting underlying EBITDA to be 3% below consensus, leading to a 4% share price decline. (tradingview.com)
Sartorius issued a profit warning in July 2024, leading to a 10% drop in share price and raising concerns about future earnings visibility. (marketscreener.com)
Analysts have described 2025 as a 'black box' for Sartorius, indicating uncertainty and potential risks in the company's future performance. (marketscreener.com)
Data summarised monthly by Lightyear AI. Last updated on 1 Jul 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sartorius Aktiengesellschaft stock?
Sartorius Aktiengesellschaft (SRT) has a market cap of €13B as of July 16, 2025.
What is the P/E ratio for Sartorius Aktiengesellschaft stock?
The price to earnings (P/E) ratio for Sartorius Aktiengesellschaft (SRT) stock is 0 as of July 16, 2025.
Does Sartorius Aktiengesellschaft stock pay dividends?
Yes, the Sartorius Aktiengesellschaft (SRT) stock pays dividends to shareholders. As of July 16, 2025, the dividend rate is €0.73 and the yield is 0.42%. Sartorius Aktiengesellschaft has a payout ratio of 53.03% on a trailing twelve-month basis.
When is the next Sartorius Aktiengesellschaft dividend payment date?
The next Sartorius Aktiengesellschaft (SRT) dividend payment date is unconfirmed.
What is the beta indicator for Sartorius Aktiengesellschaft?
Sartorius Aktiengesellschaft (SRT) has a beta rating of 1.24. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.